Searched for
ADITYA ARORA
Rakesh Bedi's Raakh OTT release: When and where to watch this crime thrillerA new crime thriller series, Raakh, is coming to Amazon Prime Video. It is set in late 1970s Delhi. The show follows a police investigation...- ‘Stop performing poverty’: Gurgaon-based CEO shares how a Bengaluru founder pays himself Rs 50,000 despite having Rs 5 cr in the bankStartup founders often face pressure to be extremely frugal. However, venture capital CEO Aditya Arora believes underpaying oneself can be ...
- Bengaluru founder has Rs 5 crore in bank, yet pays himself Rs 50K per month. Investor explains why it’s a ‘red flag’ : ‘The salary costs him...'Seasoned investor Aditya Arora highlighted the folly of founders underpaying themselves, citing a Bengaluru founder earning Rs 50,000 month...
- Insurer denies Rs 20 lakh life insurance claim over diabetes non-disclosure; woman fights back and wins; here’s whyA Delhi woman's Rs 20 lakh life insurance claim, denied due to alleged non-disclosure of diabetes and kidney diseases, was upheld by the St...
- Less than 24 hours in Hospital? Know about health insurance coverage for day care treatments, surgeries, and emergency proceduresMany policyholders believe health insurance claims require a 24-hour hospital stay. However, modern policies cover numerous treatments comp...
- TCS Q4 beats expectations; UP girl makes Y Combinator historyTCS reported strong Q4 results, driven by robust performance in North America and a weak rupee. This and more in today's ETtech Top 5.
- Snack companies can't break free from sugar yetIndian snack companies face challenges in reducing sugar content. Consumers, especially teenagers and parents, desire low-sugar and high-pr...
- Dhurandhar 2 box office collection: Aditya Dhar's blockbuster grosses Rs 1,365 cr, breaking lifetime record of Part 1Dhurandhar: The Revenge has achieved remarkable box office success. The film has grossed over Rs 1,365 crore globally and Rs 867 crore in I...
- Next leg of the rally from cement pack; Ultratech top pick: Aditya AroraAditya Arora from Adlytick expects the market to stay range-bound, with key levels for Nifty at 24,400 on the upside and 23,800 on the down...
- Aditya Arora on top stock pick for the dayThis stock took a lot of time to consolidate and now the stock is breaking out. So, on medium to long term timeframe, I am bullish on the s...
- 2 top stock recommendations from Aditya AroraOnce the index crosses 7,100, there could be momentum towards 7,200. As of now, we would expect that there is some time correction and pric...
- Don’t be a blind bull in this market; 2 FMCG stocks to buy now: Aditya AroraAditya Arora noted that the Nifty Mid Cap space had seen a muted recovery, regaining only about 50% of its fall. He advised a cautious, sto...
- Buy Nykaa at current price; 2 top picks for the day: Aditya AroraAditya Arora recommends buying Reliance at Rs 2970, stop loss Rs 2900, target Rs 3070. Cipla at Rs 1471, stop loss Rs 1430, target Rs 1540....
- Time for Nifty and Bank Nifty to hit new highs; be neutral to bullish on IDFC First Bank: Aditya AroraAditya Arora predicts a global-led rally with high targets for Nifty and Bank Nifty. Broad market recovery seen, with specific stock recomm...
- Market headed much higher from here; 2 stocks to bet on now: Aditya AroraAditya Arora recommends investing in Dixon Technologies at Rs 6993 with stop loss at Rs 6700 and target at Rs 7300, also suggests Lodha at ...
- Not time yet to buy NBFCs on dips; allow Tata stocks to consolidate: Aditya AroraAditya Arora advises caution in NBFC, midcap, smallcap, chemicals, power, F&O counters. Largecaps expected to outperform. Tata Chemicals sh...
- Aditya Arora on where money can be made in pharma spaceAditya Arora of Adlytick maintains a cautious view on the market due to the lack of broad-based rally. Smallcaps are correcting while safe ...
- Aditya Arora is bullish on Nifty Pharma, sees last leg of rally in high beta counters post BudgetAditya Arora is tracking Nifty Pharma and mentions good moves in Cipla, Dr Lal Path Lab, and Metropolis. The chart structure of many pharma...
- Time to lock profits in RailTel, IRFC and IRCTC as charts looking overbought: Aditya AroraAditya Arora of Adlytick believes that stocks like RailTel, RVNL, Tourism Finance, PVR-Inox, Mphasis, Torrent Pharma, SIS, and Praveg are o...
- Book some profit in GAIL, Bhel; a buy on Granules India: Aditya AroraAditya Arora says: “The high beta counters have been little overstretched and valuation is hitting the roof, Nifty Pharma index is looking ...
Load More
